Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
- Sanofi SA's (NASDAQ:SNY) Q3 sales grew 10.1% Y/Y to €10.4 billion due to solid growth from Dupixent, Vaccines, and Consumer Healthcare.
- EPS for the quarter increased 19.1% on reported and CER basis to €2.18.
- Sales from eczema treatment, Dupixent, jumped 54% to €1.41 billion.
- Vaccines sales increased 16.5% to €2.42 billion with record quarterly sales driven by flu vaccines and meningitis franchise recovery.
- Consumer Healthcare sales increased 11.1% to €1.16 billion, driven by the growth of Pain care and Digestive Wellness categories.
- The gross margin increased 1.9 percentage points to 72.8% versus the third quarter of 2020.
- Sanofi generated a free cash flow of €2.20 billion.
- Guidance: Sanofi now expects EPS to climb by around 14% at constant currencies for FY21, up from a previous, already improved estimate for 12% growth released in July.
- Read Next: Analyst Upgrades Sanofi On COVID-19 Vaccine Optimism.
- Price Action: SNY shares traded higher by 0.69% at $49.91 premarket on the last check Thursday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!